The Institution’s/Cash has spoken, page-16

Pfizer are putting $3mil plus another $1mill for R&D toward Covid 19 regardless of takeover offer

This will be used to assist emergency approval for FDA. - although not spelt out this is the next logical step.

With Pfizer as a partner the FDA will take notice and a road to approval will be assured

Pfizer want Rap to get approval as soon as possible and to be part of the family

When the first attempt by Pfizer fails there will probably be another CR to help further fund the process. Unless Pfizer continue to throw in more money or the quarterlies are better than expected.

The name of the game is to get Covid-19 FDA approval and with Pfizer we have a better chance

To obtain Emergency approval we don’t need double blind trials just a little more R&D and a big push from a big American Pharma AIMO